Differences in Use of Disease-Modifying Therapies Between Patients With Late-Onset and Adult-Onset Relapsing-Remitting Multiple Sclerosis.

Gavoille A, Kerbrat A, Edan G, Le Page E, Rollot F, Casey R, Mathey G, Stankoff B, Ciron J, De Seze J, Ruet A, Labauge PM, Kwiatkowski A, Zephir H, Papeix C, Defer G, Lebrun-Frenay C, Moreau T, Berger E, Clavelou P, Thouvenot E, Heinzlef O, Pelletier J, Al Khedr A, Casez O, Bourre B, Wahab A, David T, Magy L, Camdessanche JP, Moulin S, Doghri I, Sarov M, Dos Santos A, Pottier C, Manchon E, Aboab J, Tchikviladze M, Dahan C, Durozard P, Scherer-Gagou C, Leclancher A, Laplaud DA, Vukusic S, Michel L; for OFSEP.